6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
16m ago	Sunrun Prices $584 million Securitization of Residential Solar and Storage Assets
17m ago	Madison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
40m ago	Ultra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
40m ago	GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
41m ago	Rush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

About

Xenon Pharmaceuticals Inc (NASDAQ:XENE) — investor relations, events, news, and company updates on 6ix.

Latest News

Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting

Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting

Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering

Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS)

Financials

Revenue

$7.5 M

Market Cap

$5.43 B

EPS

-4.36

Community Chat

Ask AI